TNFRSF9 and neoplasm: Since the function of the anti-CD137 arm strongly relies on the presence of proximal PD-1 molecules, we chose PD-1 blockade-responsive tumour types, i.e., the moderately responsive CT26 model and the responsive MC38 model25,26.